Weapons Scandals Dogged President Arias
Sometimes it’s tough being a Nobel laureate. President Oscar Arias, who won the Peace Prize in 1987 for his role in the Central American peace process, drew plenty of criticism from his opponents this year for what they called doubletalk: advocating arms control abroad while opening Costa Rica to arms manufacture at home.
The conflict centered on two documents. The Central American Free-Trade Agreement with the United States (CAFTA) lists illegal weapons on its tariff schedule, prompting the Citizen Action Party (PAC) and other CAFTA critics to argue the pact would allow such arms into the country. Supporters of the agreement denied this.
The other document, a Public Health Ministry decree outlining the process of obtaining health permits for businesses, which Arias signed in August, included the manufacture of illegal arms in an annex.
The administration said the annex, created by the United Nations, did not change the country’s arms ban, but later modified the decree nonetheless. The administration then submitted a bill to expand Costa Rica’s weapons bans – prohibiting the manufacture of all firearms – to the Legislative Assembly, where at year-end it remained under discussion in the Governance Commission.
You may be interested
Costa Rica coronavirus updates for Wednesday, September 30Alejandro Zúñiga - September 30, 2020
Costa Rica announced 24 new coronavirus-related deaths over the last day for a total of 904, according to official data…
Some 34 million jobs lost in Latin America due to pandemicCarlos MANDUJANO / AFP - September 30, 2020
The two aspirers for the presidency of Costa Rica, the evangelical preacher Fabricio Alvarado and the former minister Carlos Alvarado, reach the closing of the electoral campaign for April 1st with a technical draw, according to a poll disclosed this Friday.
CureVac launches second stage of vaccine clinical trials in Peru and PanamaAFP - September 30, 2020
The German pharmaceutical company CureVac announced that it has started Phase 2 clinical trials of its experimental vaccine against Covid-19,…